1. Merck licenses UMass gastrointestinal antibody for $60M

    masshightech.com (Apr 21 2009)

    1. Merck licenses UMass gastrointestinal antibody for $60M By Mass High Tech staff A research division of the University of Massachusetts Medical School and Medarex Inc. have signed an exclusive worldwide license agreement with Merck & Co. Inc. under which Merck will develop and commercialize an ... (Read Full Article)

      Bookmark or Share this article

    Login to comment.


    Related Articles